Published: 14 March 2024
Author(s): Xinlei Miao, Manling Hu, Qianqian Wang, Guimin Tang, Song Leng
Issue: May 2024
Section: Letter to the Editor

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, affecting approximately 20–25 % of the global adult population [1]. Epidemiological evidence showed that, in addition to overweight and obesity, remnant cholesterol (RC) is the most important modifiable risk factor for the onset of NAFLD, and it has been confirmed to be a pathogenic factor in several studies [2,3]. RC can be described as the remaining fraction of cholesterol in addition to high-density lipoprotein cholesterol (HDL-C) and high-density lipoprotein cholesterol (LDL-C) [4].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.